CPH Group AG: management transactions · Switzerland · SIX SER

About CPH Group AG

CPH Group AG is a Swiss industrial group listed on the SIX Swiss Exchange (SMI/SPI) under ticker CPHN.SW. Headquartered in Perlen, Lucerne canton, Switzerland, the company completed a major strategic reset in 2024 when it spun off its paper business and the associated Perlen site real estate into a separate vehicle, Perlen Industrieholding AG. Since then, CPH Group AG has been a more focused specialty industrial company centered on two business divisions: Chemistry, operated through Zeochem, and Packaging, operated through Perlen Packaging. This sharper structure has improved transparency for investors and highlights the group’s concentration on higher-value niche markets. ([reports.cph.ch](https://reports.cph.ch/24/en/lagebericht?utm_source=openai)) The group’s industrial roots go back more than 200 years, making it one of Switzerland’s long-established manufacturing names. Over time, it evolved from a broader chemical-and-paper conglomerate into a more globally oriented specialty platform. The CPH name was adopted in 2024, replacing the former CPH Chemie + Papier Holding AG brand. Management continues to emphasize international expansion as a core pillar of strategy, supported by manufacturing and commercial operations across Europe, the United States, China, Brazil, India, Bosnia and Herzegovina, Israel and Hungary. This footprint is strategically important because it brings production closer to customers, reduces supply-chain risk and supports local market development. ([cph.ch](https://cph.ch/cph-group/history/?utm_source=openai)) Zeochem serves demanding end markets with specialty chemistry products including molecular sieves, silica gels, zeolites and deuterated products. Its portfolio is used in industrial, scientific and energy-related applications, and the division operates a multi-site global manufacturing network. Perlen Packaging supplies pharmaceutical packaging solutions, especially high-barrier blister films for solid-dose medicines. The division has built a strong reputation in PVdC-coated high-barrier films, a technically demanding niche where performance, regulatory compliance and customer qualification matter more than scale alone. In that sense, CPH’s competitive position is built on specialization rather than commodity volume. ([cph.ch](https://cph.ch/wp-content/uploads/2025/03/Geschaeftsbericht_gesamt_2024_en.pdf)) From a market perspective, CPH is positioned as a niche specialty manufacturer with Swiss industrial quality, global reach and exposure to resilient end markets such as healthcare, pharmaceuticals and advanced materials. Management has stated that the group aims to hold or achieve leadership positions in its specific market segments. Recent milestones include the 2024 spin-off of the paper division, continued internationalization, and further acquisitions in both Chemistry and Packaging that broaden capabilities and strengthen geographic coverage. These developments support a more focused investment case for shareholders seeking exposure to Swiss industrial names listed on the SIX Swiss Exchange (SMI/SPI). ([reports.cph.ch](https://reports.cph.ch/24/en/lagebericht?utm_source=openai))